Table 2 Vaccine effectiveness measures

3rd vs. 2nd vaccine group

0.08 (0.04–0.17)

92% (83–96)

0.15^ab (0.01–1.83)

0 vs. 4

0.17^ab (0.01–2.40)

0 vs. 3

0.52 (0.43–0.63)

48% (37–57)

0.08 (0.01–0.74)

92% (26–99)

0.41^ab (0.02–6.68)

0 vs. 1

2nd dose vs. unvaccinated group

0.39 (0.31–0.49)

61% (51–69)

0.03 (0.01–0.08)

97% (92–99)

0.04 (0.01–0.14)

96% (86–99)

1.12 (0.92–1.36)

[−12%] ([−36]−8)

0.49 (0.16–1.47)

51%([−47]−84)

0.17 (0.02–1.47)

83% ([−47]−98)

3rd dose vs. unvaccinated group

0.03 (0.01–0.05)

97% (95–99)

0.01^a (0.00–0.07)

99% (93–100) 0 vs. 108

0.02 ^a (0.00–0.11)

99% (89–100) 0 vs. 64

0.57 (0.47–0.69)

43% (31–53)

0.03 (0.00–0.28)

97% (72–100)

0.06^a (0.01–0.57)

94% (43–99) 0 vs. 5